Medical Journals

Regulation of the Polarity Kinases Par-1/Mark by 14-3-3 Interaction and Phosphorylation.

Authors:
  • Göransson Olga
  • Deak Maria
  • Wullschleger Stephan
  • Morrice Nick A
  • Prescott Alan R
  • Alessi Dario R

From: University of Dundee, MRC Protein Phosphorylation Unit, James Black Centre, Dow Street, Dundee, DD1 5EH, Scotland, UK. Olga.Goransson@med.lu.se

Journal of cell science

  • Publish Date: Oct 2006
  • ISSN: 0021-9533
  • Volume: 119
  • Issue: Pt 19
  • Pages: 4059-70
  • Medium: Print
  • Language: English
  • Citation (JAMA): Göransson Olga, Deak Maria, Wullschleger Stephan, et al. Regulation of the Polarity Kinases Par-1/Mark by 14-3-3 Interaction and Phosphorylation.. J. Cell. Sci. Oct 2006;119:4059-70

Abstract

Members of the PAR-1/MARK kinase family play critical roles in polarity and cell cycle control and are regulated by 14-3-3 scaffolding proteins, as well as the LKB1 tumour suppressor kinase and atypical protein kinase C (PKC). In this study, we initially investigated the mechanism underlying the interaction of mammalian MARK3 with 14-3-3. We demonstrate that 14-3-3 binding to MARK3 is dependent on phosphorylation, and necessitates the phosphate-binding pocket of 14-3-3. We found that interaction with 14-3-3 was not mediated by the previously characterised MARK3 phosphorylation sites, which led us to identify 15 novel sites of phosphorylation. Single point mutation of these sites, as well as the previously identified LKB1-(T211) and the atypical PKC sites (T564/S619), did not disrupt 14-3-3 binding. However, a mutant in which all 17 phosphorylation sites had been converted to alanine residues (termed 17A-MARK3), was no longer able to bind 14-3-3. Wild-type MARK3 was present in both the cytoplasm and plasma membrane, whereas the 17A-MARK3 mutant was strikingly localised at the plasma membrane. We provide data indicating that the membrane localisation of MARK3 required a highly conserved C-terminal domain, which has been termed kinase-associated domain-1 (KA-1). We also show that dissociation of 14-3-3 from MARK3 did not affect catalytic activity, and that a MARK3 mutant, which could not interact with 14-3-3, was normally active. Finally, we establish that there are significant differences in the subcellular localisation of MARK isoforms, as well as in the impact that atypical PKC overexpression has on 14-3-3 binding and localisation. Collectively, these results indicate that 14-3-3 binding to MARK isoforms is mediated by multiple phosphorylation sites, and serves to anchor MARK isoforms in the cytoplasm.

Mesh Headings (Keywords): 14-3-3 Proteins, Binding Sites, Cell Polarity, Cells, Cultured, Cytoplasm, Humans, Models, Molecular, Phosphorylation, Protein Binding, Protein Isoforms, Protein Kinase C, Protein Structure, Tertiary, Protein-Serine-Threonine Kinases, Tissue Distribution


Check for Full Text / PubMed Unique Identifier (PMID): 16968750


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.